Angiotensin receptor-neprilysin inhibitors (ARNIs) represent a significant advancement in heart failure therapy, combining an ...

M ore than 6 million adults in the United States have heart failure. Of these, about half have diastolic heart failure and the other half have systolic heart failure. In February 2021, the U.S. Food ...

Please provide your email address to receive an email when new articles are posted on . Fewer patients with hyperkalemia were prescribed renin-angiotensin-aldosterone system inhibitors for HF.

"We are headed down the road of increasing development and utilization of devices to treat heart failure," Dr. William ...

The proportion of people with heart failure receiving optimal therapy increased significantly with expansion of this initiative within a general cardiology practice.

In the U.S. alone, more than 6.7 million people have heart failure, a number that is projected to increase to more than 8.5 ...

Woo MA, Macey PM, Keens PT, et al. Functional abnormalities in brain areas that mediate autonomic nervous system control in advanced heart failure. J Card Fail. 2005;11:437-446. Heart failure (HF) ...

A new experimental therapy helps restore the heart’s flexibility in models of stiffened heart failure. Michael Gotthardt and his colleagues at the Max Delbrück Center are working with U.S. researchers ...